MedTrace Logo

MRA and ABR as Early Predictors of Bilirubin-Induced Neurologic Dysfunction in Full-term Jaundiced Neonates

NCT06018012 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 76

Last updated 2023-09-01

No results posted yet for this study

Summary

The aim of the research was to define the role of MRS and ABR as early predictors of bilirubin-induced neurologic dysfunction (BIND) in full-term neonates who required intervention (phototherapy or exchange transfusion).

Conditions

  • Neonatal Hyperbilirubinemia

Interventions

DEVICE

MRS and ABR

Magnetic Resonance Spectroscopy and Auditory Brain- stem Response Audiometry

Sponsors & Collaborators

  • Tanta University

    lead OTHER

Eligibility

Min Age
1 Day
Max Age
28 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2021-03-01
Completion
2021-04-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06018012 on ClinicalTrials.gov